STRO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Sutro Biopharma

NASDAQ | STRO

7.50

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$79.09M

Market Cap

-

P/E Ratio

-2.6

EPS

$9.36

52 Week High

$0.52

52 Week Low

HEALTHCARE

Sector

STRO Chart

Recent Chart
Price Action

STRO Technicals

Tags:

STRO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $55M
Total Revenue $62M
Cost Of Revenue $7.2M
Costof Goods And Services Sold $7.2M
Operating Income -$238M
Selling General And Administrative $48M
Research And Development $252M
Operating Expenses $293M
Investment Income Net -
Net Interest Income $13M
Interest Income $44M
Interest Expense $31M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.2M
Income Before Tax -$225M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$227M
Comprehensive Income Net Of Tax -
Ebit -$188M
Ebitda -$180M
Net Income -$227M

Revenue & Profitability

Earnings Performance

STRO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $387M
Total Current Assets $343M
Cash And Cash Equivalents At Carrying Value $190M
Cash And Short Term Investments $190M
Inventory -
Current Net Receivables $8.6M
Total Non Current Assets $44M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $127M
Other Current Assets $18M
Other Non Current Assets -
Total Liabilities $343M
Total Current Liabilities $132M
Current Accounts Payable $10M
Deferred Revenue -
Current Debt -
Short Term Debt $7.5M
Total Non Current Liabilities $211M
Capital Lease Obligations $23M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $204M
Other Current Liabilities $44M
Other Non Current Liabilities $1.7M
Total Shareholder Equity $45M
Treasury Stock -
Retained Earnings -$787M
Common Stock $83K
Common Stock Shares Outstanding $77M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$192M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $7.2M
Capital Expenditures $3.1M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $219M
Cashflow From Financing $94M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$227M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $55M
Total Revenue $62M
Cost Of Revenue $7.2M
Costof Goods And Services Sold $7.2M
Operating Income -$238M
Selling General And Administrative $48M
Research And Development $252M
Operating Expenses $293M
Investment Income Net -
Net Interest Income $13M
Interest Income $44M
Interest Expense $31M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.2M
Income Before Tax -$225M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$227M
Comprehensive Income Net Of Tax -
Ebit -$188M
Ebitda -$180M
Net Income -$227M

STRO News

STRO Profile

Sutro Biopharma Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, specializing in the discovery and development of innovative antibody-drug conjugates (ADCs) through its proprietary cell-free protein synthesis technology. The company is focused on advancing a diverse pipeline of targeted therapies aimed at treating cancer and other serious diseases, leveraging its expertise in protein engineering and biologics manufacturing. Sutro's commitment to precision medicine positions it strategically for growth and potential partnerships in the dynamic biopharmaceutical sector, addressing critical unmet medical needs.

LPTX
+368.57%
$2.05
VRAX
+54.64%
$0.60
PAVS
-39.92%
$0.03
IXHL
+14.75%
$0.45
VHAI
0.00%
$0.00
IRBT
+60.25%
$3.12
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
NVDA
-0.60%
$180.36
AXDX
-61.36%
$0.03
ONDS
-2.81%
$7.84
JSPR
-8.13%
$1.58
NIO
-5.66%
$4.74
ADAP
-15.14%
$0.05
TSLA
+2.65%
$440.65
AMZN
+0.23%
$234.42
SOND
-23.45%
$0.12
BYND
-4.55%
$1.23
INTC
+0.18%
$43.55
ASST
-1.93%
$1.01
RMBL
+60.50%
$3.21
QCLS
+20.41%
$4.07
CAPR
+345.75%
$28.35
LNW
-3.71%
$86.22
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
RR
+1.96%
$3.63
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
PLUG
+1.95%
$2.15
VALE
+2.87%
$13.26
MRVL
+3.97%
$96.58
BITF
-2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
PFE
+2.12%
$25.68
NFLX
+0.20%
$109.35
SOFI
+0.16%
$29.55
AFMD
-34.94%
$0.18
KITT
+28.86%
$0.93
BBD
-2.46%
$3.57
IMRN
-12.06%
$1.53
PMAX
+23.73%
$2.80
F
+1.35%
$13.13
HTOO
+14.85%
$4.02
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AAL
+0.56%
$14.32
QBTS
+2.12%
$22.97
DNN
+1.15%
$2.62
CMND
-13.27%
$0.11
AAPL
+0.06%
$286.39
CCL
-0.34%
$25.84
CHR
-6.96%
$0.04
ASBP
-14.91%
$0.08
MSFT
-2.02%
$480.09
PLTD
-1.79%
$6.83
AMC
-2.12%
$2.30
MARA
+0.20%
$11.93
CIFR
-0.68%
$17.52
AEO
+14.17%
$23.78
AMD
+0.01%
$215.26
PYPL
-2.90%
$61.07
CLSK
+0.84%
$13.82
GOOGL
+1.42%
$320.32
ACHR
+3.50%
$7.91
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
CSCO
+1.09%
$76.87
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PLTR
+1.52%
$173.28
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
BTG
+1.01%
$4.47
ZAPP
-46.30%
$0.15
LYFT
+3.73%
$22.24
KXIN
+27.41%
$3.95
BMY
+5.41%
$50.86
VIVK
-13.43%
$0.09
MSTR
-0.02%
$181.28
KEY
-0.72%
$18.28
SU
-1.91%
$43.94
HIMS
-3.19%
$36.31
PINS
+0.18%
$26.89
ON
+2.08%
$51.48
PSTG
-26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI
-0.10%
$23.85
M
+0.15%
$22.74
NBIS
-3.69%
$96.45
GOOG
+1.57%
$321.01
CGC
+2.25%
$1.13
AG
-0.53%
$15.82
IONZ
+0.51%
$4.48
LPTX
+368.57%
$2.05
VRAX
+54.64%
$0.60
PAVS
-39.92%
$0.03
IXHL
+14.75%
$0.45
VHAI
0.00%
$0.00
IRBT
+60.25%
$3.12
TWOH
0.00%
$0.00
IPG
-1.95%
$24.57
NVDA
-0.60%
$180.36
AXDX
-61.36%
$0.03
ONDS
-2.81%
$7.84
JSPR
-8.13%
$1.58
NIO
-5.66%
$4.74
ADAP
-15.14%
$0.05
TSLA
+2.65%
$440.65
AMZN
+0.23%
$234.42
SOND
-23.45%
$0.12
BYND
-4.55%
$1.23
INTC
+0.18%
$43.55
ASST
-1.93%
$1.01
RMBL
+60.50%
$3.21
QCLS
+20.41%
$4.07
CAPR
+345.75%
$28.35
LNW
-3.71%
$86.22
BTBT
-0.44%
$2.24
ADD
-25.47%
$0.05
RR
+1.96%
$3.63
IREN
+4.95%
$43.15
INHD
-9.37%
$0.13
SRM
+53.27%
$10.30
PLUG
+1.95%
$2.15
VALE
+2.87%
$13.26
MRVL
+3.97%
$96.58
BITF
-2.65%
$3.01
BMNR
+3.44%
$33.01
BMNU
+6.13%
$7.79
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
PFE
+2.12%
$25.68
NFLX
+0.20%
$109.35
SOFI
+0.16%
$29.55
AFMD
-34.94%
$0.18
KITT
+28.86%
$0.93
BBD
-2.46%
$3.57
IMRN
-12.06%
$1.53
PMAX
+23.73%
$2.80
F
+1.35%
$13.13
HTOO
+14.85%
$4.02
GRYP
-10.38%
$1.38
BTE
-1.55%
$3.17
MODV
-25.22%
$0.43
AAL
+0.56%
$14.32
QBTS
+2.12%
$22.97
DNN
+1.15%
$2.62
CMND
-13.27%
$0.11
AAPL
+0.06%
$286.39
CCL
-0.34%
$25.84
CHR
-6.96%
$0.04
ASBP
-14.91%
$0.08
MSFT
-2.02%
$480.09
PLTD
-1.79%
$6.83
AMC
-2.12%
$2.30
MARA
+0.20%
$11.93
CIFR
-0.68%
$17.52
AEO
+14.17%
$23.78
AMD
+0.01%
$215.26
PYPL
-2.90%
$61.07
CLSK
+0.84%
$13.82
GOOGL
+1.42%
$320.32
ACHR
+3.50%
$7.91
KDLY
-2.95%
$0.48
CMG
-0.29%
$34.14
CSCO
+1.09%
$76.87
WULF
-4.04%
$13.64
SAND
-6.04%
$12.12
PLTR
+1.52%
$173.28
SHOT
-74.37%
$0.39
GTLB
-14.56%
$37.05
YGMZ
-14.61%
$0.07
BTG
+1.01%
$4.47
ZAPP
-46.30%
$0.15
LYFT
+3.73%
$22.24
KXIN
+27.41%
$3.95
BMY
+5.41%
$50.86
VIVK
-13.43%
$0.09
MSTR
-0.02%
$181.28
KEY
-0.72%
$18.28
SU
-1.91%
$43.94
HIMS
-3.19%
$36.31
PINS
+0.18%
$26.89
ON
+2.08%
$51.48
PSTG
-26.10%
$69.99
GPUS
-5.12%
$0.27
RGTI
-0.10%
$23.85
M
+0.15%
$22.74
NBIS
-3.69%
$96.45
GOOG
+1.57%
$321.01
CGC
+2.25%
$1.13
AG
-0.53%
$15.82
IONZ
+0.51%
$4.48
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.